Justification and Approval for Sole Source TPOXX Requirement
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- JA-24-Edg-632
- Agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W911SR-24-C-0030 Federal contract award
- Awardee
- Siga Technologies, Inc.
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- New York, New York 10065, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Limited/Sole Source Justification Notice is for the Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground (ACC Aberdeen Proving Ground) to procure additional doses of oral TPOXX and IV TPOXX treatment courses to maintain the national stockpile of smallpox therapeutics. The sole source contract will be awarded to Siga Technologies Inc. for an unknown amount on August 2, 2024. Both TPOXX treatment courses have been approved by the FDA, and the purpose of the sole source award is to ensure the continued availability of these critical smallpox therapeutics in the national stockpile.
Notice text
The purpose of this other than full and open competition contract to Siga Technologies Inc., is to procure additional doses
of oral TPOXX treatment courses and IV treatment courses to maintain the national stockpile of smallpox therapeutics. Both TPOXX treatment courses have been approved by the United States Food and Drug Administration.
Awarded contract W911SR-24-C-0030 to unknown vendor for unknown amount on 2024-08-02.
Files
| File | Type | Posted |
|---|---|---|
| JA-24-Edg-632_TPOXX_Redacted.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity